Synthesis, characterization and application of epichlorohydrin-β-cyclodextrin polymer.

Area of Science:

• Pharmaceutical Sciences
• Biomedical Engineering
• Materials Science

Background:

• Cyclodextrins are macrocyclic compounds known for their drug inclusion capabilities.
• Chemically modified and polymerized cyclodextrin derivatives enhance physicochemical and biopharmaceutical properties.
• Polymerized cyclodextrins offer advantages like high molecular weight and solubility, surpassing parent cyclodextrins.

Purpose of the Study:

• To review the potential of polymerized water-soluble β-cyclodextrin derivatives, specifically epichlorohydrin-β-cyclodextrin polymer, in drug delivery.
• To highlight the superiority of polymerized cyclodextrins over other derivatives due to combined polymer and cyclodextrin properties.
• To discuss the increasing applications of polymerized cyclodextrins in biomedical, pharmaceutical, and gene delivery systems.

Main Methods:

• Review of existing literature on polymerized cyclodextrins and their applications.
• Analysis of the properties of epichlorohydrin-β-cyclodextrin polymer as a drug carrier.
• Discussion of the advantages offered by polymerized cyclodextrins in drug formulation.

Main Results:

• Epichlorohydrin-β-cyclodextrin polymer acts as an effective drug carrier, enhancing drug solubility and oral bioavailability.
• Polymerized cyclodextrins increase therapeutic efficiency and are suitable for various drug delivery routes.
• The use of polymerized cyclodextrins in drug delivery is expanding across biomedical and pharmaceutical fields.

Conclusions:

• Polymerized cyclodextrins are superior drug carriers with significant potential in pharmaceutical science.
• Further research is needed on the regulatory status and toxicity of polymerized cyclodextrins for commercialization.
• These compounds represent multifunctional tools for optimizing drug delivery systems through diverse administration routes.